Almirall Announces Partnership With Microsoft for Digital Transformation, Development of Skin Disease Treatments. Dermatology Times [online]. 2024-01-31 [cit. 2024-06-15]. Dostupné online.
thepharmaletter.com
Almirall revenue growth adds credibility to dermatology leadership claim. Tje Pharma Letter [online]. 2024-02-19 [cit. 2024-06-15]. Dostupné online.
yahoo.com
finance.yahoo.com
Almirall Licenses an Anti-IL-21 Monoclonal Antibody From Novo Nordisk to Develop It as a First-in-Class Agent in Dermatology. Yahoo! Finance [online]. 2024-05-19 [cit. 2024-06-15]. Dostupné online.
